HomeNEO • NASDAQ
NeoGenomics, Inc.
$15.72
After Hours:
$15.72
(0.00%)0.00
Closed: Mar 28, 4:03:24 PM GMT-4 · USD · NASDAQ · Disclaimer
StockUS listed securityUS headquartered
Previous close
$15.20
Day range
$15.09 - $15.91
Year range
$11.03 - $21.22
Market cap
2.01B USD
Avg Volume
1.03M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
(USD)Dec 2023Y/Y change
Revenue
155.55M12.15%
Operating expense
84.96M-2.11%
Net income
-14.33M36.85%
Net profit margin
-9.2143.70%
Earnings per share
0.03150.00%
EBITDA
992.00K108.34%
Effective tax rate
6.28%
Total assets
Total liabilities
(USD)Dec 2023Y/Y change
Cash and short-term investments
415.20M-5.20%
Total assets
1.68B-3.38%
Total liabilities
739.69M-0.31%
Total equity
941.54M
Shares outstanding
127.61M
Price to book
2.06
Return on assets
-2.58%
Return on capital
-2.80%
Net change in cash
(USD)Dec 2023Y/Y change
Net income
-14.33M36.85%
Cash from operations
17.78M582.61%
Cash from investing
17.20M1,717.59%
Cash from financing
1.27M-29.52%
Net change in cash
36.25M1,330.45%
Free cash flow
10.85M182.93%
About
NeoGenomics Laboratories, Inc., also known as NeoGenomics or Neo, is a high-complexity CLIA-certified clinical laboratory, pharma services and information services company that specializes in cancer genetics diagnostic testing. The company's testing services include cytogenetics, fluorescence in situ hybridization, flow cytometry, immunohistochemistry, anatomic pathology, and molecular genetics. Headquartered in Fort Myers, FL, NeoGenomics maintains a network of testing facilities across the US, with laboratories in Florida, California, Tennessee, and Texas. Wikipedia
Founded
2002
Employees
2,100
Discover more
You may be interested in
This list is generated from recent searches, followed securities, and other activity. Learn more

All data and information is provided “as is” for personal informational purposes only, and is not intended to be financial advice nor is it for trading purposes or investment, tax, legal, accounting or other advice. Google is not an investment adviser nor is it a financial adviser and expresses no view, recommendation or opinion with respect to any of the companies included in this list or any securities issued by those companies. Please consult your broker or financial representative to verify pricing before executing any trades. Learn more
People also search for
Search
Clear search
Close search
Google apps
Main menu